Pharmaceutical Technology19d agobullish
MSD wins FDA approval for cholesterol pill to help plug Keytruda voidMSD has outpaced rivals to market the first PCSK9 inhibitor in pill form for patients with high cholesterol.
News
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
527last 24h
2508last 7d
482● bullish (7d)
256● bearish (7d)
197publishers
Insider Monkey38d agobullish
Gilead (GILD) Wins FDA Approval for Trodelvy in TNBCGilead Sciences, Inc. (NASDAQ:GILD) is one of the 12 Most Profitable S&P 500 Stocks to Invest In. On June 25, 2026, the Food and Drug Administration approved Trodelvy from Gilead Sciences, Inc. (NASDAQ:GILD) for two indications in adults with triple-negative breast cancer. The first approval covers sacituzumab govitecan-hziy as a single agent for the first-line […]